Clinical Trial Update: GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GSK189075 and GW869682 against placebo in type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK189075 (GSK189075)
• GW869682

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2, Non-Insulin-Dependent Diabetes Mellitus | Phase 2 | Status: COMPLETED